XIAP and plasma cell myeloma: XIAP overexpression in turn has been reported in childhood acute myeloid leukemia (AML)121, renal carcinoma122,123, multiple myeloma (MM)124, and bladder cancers125, and AML patients with low levels of expression of XIAP were shown to have a statistically significant survival advantage compared with those patients with higher levels120,126.